| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/24/2002 | WO2002083712A2 Transporters and ion channels |
| 10/24/2002 | WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 10/24/2002 | WO2002083709A2 Kinases and phosphatases |
| 10/24/2002 | WO2002083704A1 Vascular endothelial growth factor 2 |
| 10/24/2002 | WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 10/24/2002 | WO2002083576A1 A process for biochemical treatment of waste water using nano materials |
| 10/24/2002 | WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 10/24/2002 | WO2002083184A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 10/24/2002 | WO2002083183A2 Stimulation of the immune system |
| 10/24/2002 | WO2002083179A2 Fusion proteins |
| 10/24/2002 | WO2002083080A2 Method of treating arthritis using lentiviral vectors in gene therapy |
| 10/24/2002 | WO2002083076A2 Method for inhibiting atherosclerotic plaque formation |
| 10/24/2002 | WO2002083075A2 Akt and regulation of ra synovial fibroblast apoptosis |
| 10/24/2002 | WO2002083074A2 Methods for the treatment of hepatic disorders |
| 10/24/2002 | WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 10/24/2002 | WO2002083069A2 Recombinant proteins of orientia tsutsugamushi |
| 10/24/2002 | WO2002083067A2 Prodrugs via acylation with cinnamate |
| 10/24/2002 | WO2002083064A2 A method of treating cancer |
| 10/24/2002 | WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 10/24/2002 | WO2002082986A1 Imaging of a region in a scattering medium |
| 10/24/2002 | WO2002082908A1 Method of treating arthritis using lentiviral vectors in gene therapy |
| 10/24/2002 | WO2002082904A2 Method of treating or retarding the development of blindness |
| 10/24/2002 | WO2002082898A1 Novel endophytic fungi and methods of use |
| 10/24/2002 | WO2002082889A1 A method to control the ripening of papaya fruit and confer disease resistance to papaya plants |
| 10/24/2002 | WO2002067665A3 Cloning of transgenic animals comprising artificial chromosomes |
| 10/24/2002 | WO2002065091A3 Pin1 as marker for abnormal cell growth |
| 10/24/2002 | WO2002064746A3 Combined transductional and transcriptional targeting system for improved gene delivery |
| 10/24/2002 | WO2002064015A8 Pin1 as a marker for prostate cancer |
| 10/24/2002 | WO2002062995A3 Human dorsal root receptor-like g protein-coupled receptor |
| 10/24/2002 | WO2002062951A3 Antisense modulation of casein kinase 2-alpha prime expression |
| 10/24/2002 | WO2002060931A3 A fimbria-like gene in bifidobacteria |
| 10/24/2002 | WO2002057226A9 68730 and 69112 protein kinase molecules and uses therefor |
| 10/24/2002 | WO2002048380A3 Glycosilated cationic lipids for liposomes used in drug delivery |
| 10/24/2002 | WO2002046367A3 Antisense modulation of cellular apoptosis susceptibility gene expression |
| 10/24/2002 | WO2002045524A3 Prolyl endoprotease from aspergillus niger |
| 10/24/2002 | WO2002042419A3 Cell culture apparatus and methods of use |
| 10/24/2002 | WO2002040715A8 Molecules for disease detection and treatment |
| 10/24/2002 | WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof |
| 10/24/2002 | WO2002038739A3 Bacterial expression systems |
| 10/24/2002 | WO2002022830A3 Transglutaminase gene products |
| 10/24/2002 | WO2002022800A3 Expression cassettes and adenovirus vectors |
| 10/24/2002 | WO2002022777A3 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 10/24/2002 | WO2002016569A3 38618, a human alpha/beta hydrolase and uses thereof |
| 10/24/2002 | WO2002010425A3 Ascorbic acid production from yeasts |
| 10/24/2002 | WO2002006462A3 Methylated nucleotide regulation of upa gene expression |
| 10/24/2002 | WO2002002761A3 57658, a human uridine kinase and uses thereof |
| 10/24/2002 | WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2 |
| 10/24/2002 | WO2001096399A3 Novel interferon-induced tetraspan protein and nucleic acids encoding same |
| 10/24/2002 | WO2001077375A8 Diagnosis of diseases associated with gene regulation |
| 10/24/2002 | WO2001073052A3 Thermophilic polymerase iii holoenzyme |
| 10/24/2002 | WO2001073038A3 Method for the biotechnological production of l-alaninol |
| 10/24/2002 | WO2001071036A3 Methods of preparing amplified nucleic acid molecules |
| 10/24/2002 | WO2001068911A8 Diagnosis of diseases associated with the cell cycle |
| 10/24/2002 | WO2001064861A3 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target |
| 10/24/2002 | WO2001062975A9 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 10/24/2002 | WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof |
| 10/24/2002 | WO2001061005A3 Molecules of the pyrin domain protein family and uses thereof |
| 10/24/2002 | WO2001059114A9 Tumor suppressor gene, p47ing3 |
| 10/24/2002 | WO2001059103A9 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 10/24/2002 | WO2001059092A9 Methods for generating hypermutable bacteria |
| 10/24/2002 | WO2001059073A9 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 10/24/2002 | WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 10/24/2002 | WO2001055298A8 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins |
| 10/24/2002 | WO2001049865A9 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp |
| 10/24/2002 | WO2001044510A3 Nucleic acid amplification and detection of mycobacterium species |
| 10/24/2002 | WO1999064449A3 Cell-permeable peptide |
| 10/24/2002 | WO1999050288A3 Mammalian blood loss-induced gene, kd312 |
| 10/24/2002 | US20020157143 Soybean plants with enhanced yields and methods for breeding for and screening of soybean plants with enhanced yields |
| 10/24/2002 | US20020157142 Herbicide target genes and methods |
| 10/24/2002 | US20020157140 Esr1 - a plant gene that can promote plant regeneration and transformation |
| 10/24/2002 | US20020157139 Soybean transformation method |
| 10/24/2002 | US20020157138 Transformation and regeneration of sunflower cotyledons |
| 10/24/2002 | US20020157137 Nucleic acids that control reproductive development in plants |
| 10/24/2002 | US20020157136 Plant having altered environmental stress tolerance |
| 10/24/2002 | US20020157135 Selecting first codon of parent polynucleotide for replacement with synonymous codon which has higher translational efficiency in target cell than in other cell, replacing first codon with synonymous codon |
| 10/24/2002 | US20020157133 Genetic functions required for gene silencing in maize |
| 10/24/2002 | US20020157132 Polynucleotide that encodes a plant cysteine gamma synthase |
| 10/24/2002 | US20020157131 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 10/24/2002 | US20020157130 For identifying genes the enhanced expression of which results in plants having desired traits; using recombinant DNA technology |
| 10/24/2002 | US20020157129 Use of male-sterile plant for avoiding dissemination of transgene of interest which is integrated into genome of plant |
| 10/24/2002 | US20020157128 Removal of metals from contaminated substrates by plants |
| 10/24/2002 | US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors |
| 10/24/2002 | US20020157126 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass |
| 10/24/2002 | US20020157125 Growth differentiation factor-8 |
| 10/24/2002 | US20020157124 Transgenic rodents and rodent cell lines expressing HIV co-receptors |
| 10/24/2002 | US20020157123 Compositions and methods for treating enzyme deficiency |
| 10/24/2002 | US20020157122 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
| 10/24/2002 | US20020157121 Propagation of human hepatocytes in non-human animals |
| 10/24/2002 | US20020157120 Circularly permuted fluorescent protein indicators |
| 10/24/2002 | US20020157119 Identification of activated receptors and ion channels |
| 10/24/2002 | US20020157118 Human neurofilament genes may be introduced into such genetically non-human animals to produce improved models of physiology of human neurofilament proteins which may be used to study human neurodegenerative disorders |
| 10/24/2002 | US20020156585 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) |
| 10/24/2002 | US20020156267 High affinity, low molecular weight displacers for oligonucleotide purification |
| 10/24/2002 | US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto |
| 10/24/2002 | US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders |
| 10/24/2002 | US20020156262 Polypeptides having lysophosphatidic acid acyltransferase activity and polynucleotides encoding polypeptides having LPAAT activity |
| 10/24/2002 | US20020156261 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma |
| 10/24/2002 | US20020156260 Gene encoding a polypeptide having pre-B cell growth-supporting ability |
| 10/24/2002 | US20020156259 Human adenosine deaminase |
| 10/24/2002 | US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |